[Federal Register Volume 60, Number 213 (Friday, November 3, 1995)]
[Notices]
[Pages 55846-55847]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-27322]



-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

International Cancer Information Center; Office of the Director; 
National Cancer Institute; Journal

AGENCY: National Institutes of Health, PHS, DHHS.

ACTION: Advertisement.

-----------------------------------------------------------------------

    Opportunity for a Cooperative Research and Development Agreement 
(CRADA) for the development within the private sector of the capability 
of producing a rapid turn-around multi-disciplinary cancer journal that 
satisfies the need of the National Cancer Program for the dissemination 
of high quality peer-reviewed, research that bears on the etiology, 
biology, detection, prevention, and treatment of cancer. The journal 
must also provide high quality scientific peer-reviewed articles, 
reviews, editorials, commentaries and news.

SUMMARY: The International Cancer Information Center of the National 
Cancer Institute, NIH is seeking a Collaborator with an international 
reputation in the biomedical research and clinical practice 
communities, as demonstrated by:
     The quality of its information products, particularly its 
biomedical journals;
     Its commitment to the advancement of science and medical 
practice, as evidenced by indicators of a high level of satisfaction by 
health professionals with products and services, the range of products 
and services offered, and the impact of its journal(s) as measured by 
the Institute for Scientific Information (ISI) impact factors.
    The Collaborator must be able to collaborate with NCI staff to 
produce high quality information products. The Collaborator must have a 
demonstrated record of success in privately producing biomedical and 
clinical information resources.
    The term of the CRADA will be five (5) years.

ADDRESSES: Inquiries and proposals regarding this opportunity should be 
addressed to William Joseph Cotreau (Tel.# 301-496-0477, FAX# 301-402-
2117), Office of Technology Development, National Cancer Institute, 
Building 31, Room 4A49, NIH, 9000 Rockville Pike, Bethesda, MD 20892.

DATES: Interested parties should notify this office in writing no later 
than sixty (60) days from the date of this announcement in the Federal 
Register. Respondents will then be given an additional sixty (60) days 
for filing a formal proposal.

SUPPLEMENTARY INFORMATION: A Cooperative Research and Development 
Agreement (CRADA) is the anticipated joint agreement to be entered into 
by NCI pursuant to the Federal Technology Transfer Act of 1986 and 
Executive Order 12591 of October 10, 1987. Under the present proposal, 
the goal of the CRADA will be the development of the following 
technology.
    A rapid turn around multi disciplinary cancer journal (Journal of 
the National Cancer Institute--JNCI) that satisfies the need of the 
National Cancer Program for disseminating:
     High quality scientific peer-reviewed research that bears 
on the etiology, biology, detection, prevention, and treatment of 
cancer
     High quality scientific peer-reviewed articles, reviews, 
editorials and commentaries
     News
     Electronic and new media cancer information sources.
    All necessary existing rights and assets currently held by NCI for 
the production of the JNCI will be licensed as needed to the 
Collaborator.
    The Journal produced under the CRADA will operate in conformance 
with the Guidelines of the International Committee of Biomedical 
Journal Editors among other guidelines. These guidelines establish the 
editorial freedom of the editor-in-chief and maintain the integrity of 
the Journal. Editorial control and overall intellectual oversight will 
therefore be the province of the editor-in-chief. The editor-in-chief 
will be appointed by the NCI and approved by the Collaborator. NCI and 
Collaborator staff will contribute to achieving the intellectual goals 
determined by the editor-in-chief. The Collaborator will also 
contribute the business and marketing expertise and the technical, 
management, and R&D expertise required for the maintenance and 
dissemination of a derivative electronic journal or information 
product.

Party Contributions

    The role of the NCI includes the following:
    (1) Cooperate with Collaborator to jointly produce the Journal of 
the National Cancer Institute and related information products;
    (2) Provide the Editor-in-Chief for the JNCI and related 
information products;
    (3) Provide all line staff functions for the publication of the 
JNCI and related information products until the Collaborator is able to 
provide the same to the satisfaction of the Editor-in-Chief, including 
assistance with maintainence of the mailing list;
    (4) Evaluate the work product of Collaborator to ensure progress 
toward meeting the CRADA goals;
    (5) Provide work space and equipment for production of the JNCI and 
related information products until the Collaborator is able to provide 
the same to the satisfaction of the Editor-in-Chief.
    The role of the successful Collaborator will include the following:
    (1) Transition to independently produce the JNCI and related 
information products;
    (2) Provide funding, as necessary, in support of production and 
dissemination of information products;
    (3) Provide expertise in production and marketing of biomedical 
information products;
    (4) Provide resources to market biomedical information products;
    (5) Cooperate with Editor-in-Chief in all aspects of meeting 
information needs of the National Cancer Program;
    (6) Invoice accounts and receive, process, and disburse funds for 
NCI;
    (7) Maintain mailing list electronically in a database of the NCI's 
choice.

Selection Criteria

    Proposals submitted for consideration should fully address each of 
the following qualifications:
    1. Expertise:
    A. Demonstrated expertise in developing and producing high quality 
biomedical print journals (and spin off print and electronic biomedical 
information products);
    B. Demonstrated expertise in overseeing all aspects of product 
development;
    C. Demonstrated intellectual ability to guide development of 
product line which addresses the requirements of the National Cancer 
Program;
    D. Demonstrated expertise in conducting rapid peer and editorial 
review of biomedical information products;
    E. Demonstrated expertise in techniques of fast production of 
publications and information materials;
    F. Demonstrated expertise in marketing of biomedical information 
products;
    G. Demonstrated expertise in subscription management, advertising, 
fulfilment and customer service;
    H. Knowledge of basic and clinical research, including but not 
limited to: 

[[Page 55847]]
Research in the biology, treatment, detection, and prevention of 
disease;
    I. Experience in publishing biomedical research;
    J. Demonstrated proficiency in serving a large membership base.
    2. Reputation:
    The successful Collaborator must be recognized in the biomedical 
research and clinical practice communities for:
    A. The quality of its information products, particularly its 
biomedical journals;
    B. Its commitment to the advancement of science and medical 
practice;
    C. Indications of high levels of satisfaction by health 
professionals with the information products and services;
    D. The range of products and services;
    E. The impact of its journal(s) as measured by the Institute for 
Scientific Information (ISI).
    3. Physical Resources:
    A. An established headquarters with offices, space and equipment;
    B. Personal access to the organization during business hours;
    C. Access to the organization during business hours by telephone, 
mail,     e-mail, the Internet and other evolving technologies;
    D. Sufficient financial resources to support, at a minimum, the 
current activities of the JNCI to meet the needs of the National Cancer 
Program.

    Dated: October 26, 1995.
Thomas Mays,
Director, Office of Technology Development, National Cancer Institute, 
National Institutes of Health.
[FR Doc. 95-27322 Filed 11-2-95; 8:45 am]
BILLING CODE 4140-01-P